Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial)
Author: Maki, K.
Orloff, D.
Nicholls, S.
Dunbar, R.
Roth, E.
Curcio, D.
Johnson, J.
Kling, D.
Davidson, M.
Citation: Clinical Therapeutics: the international peer-reviewed journal of drug therapy, 2013; 35(9):1400-1411
Publisher: Elsevier
Issue Date: 2013
ISSN: 0149-2918
Statement of
Kevin C. Maki, David G. Orloff, Stephen J. Nicholls, Richard L. Dunbar, Eli M. Roth, Danielle Curcio, Judith Johnson, Douglas Kling, and Michael H. Davidson
Abstract: Abstract not available
Keywords: Hypertriglyceridemia; LDL-C; omega-3 fatty acids; statins; triglycerides
Rights: © 2013 Elsevier HS Journals, Inc. All rights reserved.
DOI: 10.1016/j.clinthera.2013.07.420
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.